ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0001197.1|Frankiamicin_1 # 1 # 3399 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.718	BGC0001197.1|Frankiamicin_1 	1	3399	+	Loose	890	33.8834	cpxA	22.22	3000830	protein homolog model	n/a	n/a	aminoglycoside antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTCCGGAATTGGCCCATCCGCTCGAAGCTAGTGGTGATTCTCATCGTCCCGCTGGCCGCGCTGGCCGTGCTGAGCGCGATACAGGTGCGCGGGGACGTCGACAACGTCCGGGCCGCGGGCCGCATCGAGGCGCTCGCCGACTTCTCGATCAAAGGTAACAACCTGGTCCACGTGCTTCAGCGGGAGCGCTATGCGACCAACTCTTACGTTGGATCGAACTTCCTCATCCCGATGCTGGGCCAGCAGGCTGTGGATGCCCGCAAGCCCGTGGACGACGCCCTCGCCATCTACCTGGCCGACGAGCAGGCACTGCCCGCGTCCGCGCGCGACGCCCTCGGCTCGACACTGAGTTCCATCCGTACGCATCTCGACCAGCTCGGCGAGCACCGCAAGCAGATCGACGCGCACCAGACCGAGATCGCGTCGAACGGGGCCTTCTACAACGAGGCCGTGAACGAGCTGCTGCTGCTCAACGCGCGGATCGCGGCCGGTAGCTCGGACGCCAAGCTGGTCAACGGCTCTACCACGCTGGCCGGTATCGCCCAGGCCAAGGAACAAGCCTCCCAGCAGCGTGGATCCGTCGCCCAGATGCTCTCCATGGGCAACCCCACGCCGCAGATGCTGCGTGCTCTGCTGGCCTACGCCGGTGCCGAGACCGCCTGGACCGAGCAGTTCCGCTCCACGGCGACGCCGGCCGAGCTGGAGCTGTTCACGAACACGGTCGGGCGCTCTGCCACCGGCGTCAACCAGATGCGCGACGACGTGGTCAACAGGTTCAGCGGGCAGCAGGCTCCCGACGTCGGCCTCGAGGCCTGGCGGACCGCCGCCGACAGCAAGATCGCGCAGATGCACGACGTCGAGGTGCAGATCGCCAACGACCTGGCGGCGACAAGTCGCGACATCGCCTCGACGGCCTCCCGGGACGCCCTGCTCGGAAGCATCGGCGTGGCGATCATTCTCGTGCTCTCGGTCGTGATCTCACTGCTCGTCGCGAGCCCCATGATCGGTCAGCTCCGCCGGCTGCGGGGTGGCGCGCTCGACGTCGCCAACGACCGGCTGCCCAGCGTCGTCGAGCGGCTGCACCGGGGTGAGCCCGTCGACATCGACGCGGAGTCCTTCCCGGTACCCGCGACCAGCAAGGACGAGATCGGCCAGCTGGCGGAGGCGTTCGCCACGGTGCACGAGGTGGCGGTGCGCACCGCCGTCGAGCAGGCCGCGATGCGCAAGAGCATCGGGGACACCTTCCTCAACCTCGCGCGCCGCAGCCAGGCCCTGATCCACCGCCAGCTGAAGATCATTGACGCGCTGGAGCGCAAGGAGACCGACCCGGACGAGCTCGAGGAGCTGTTCCGGCTCGACCACCTCGCGACCCGTATGCGGCGCCACGCCGAGGACCTCATCGTCCTCTCCGGCTCCAAGCCCGCCCGTGGCTGGCGCCGGCCGGTTCCGATCAAGGACGTCGTCCGCGGTGCCGTCGCCGAGGTCGAGGACTACACCCGGGTCAAGGTCCTGCCCATCACCGGTGGCGCCGTCTCCGGCCACGCCGTCGGTGACGTGATCCACATGTTCGCCGAGCTGATCGAGAACGCGACCTCCTTCTCGCCCCCGCACACCCCCGTGCAGGTCGCCGGGCACCCGGTCTCCAACGGCTTCGTGGTCGAGATCGAGGACCGCGGGCTCGGGATGAACCAGGAGGAGATCGACGCGCTCAACAACCGGCTGGCGAACCCGCCGCCGTTCGACCTGTCGACCAGCGAGCGGCTGGGCCTGTTCGTGGTCAGCCGGCTGGCGGAGCGGCACGACGTCCAGGTACGGCTGCGGCCGTCGCCGTACGGCGGCACGATGGCGATCGTCCTGCTGCCCGCGACCCTGCTGCGCGCCTCCGACGACAAGGGCGAGGACAGCGGCCCGCGCGAGTTCGCCGCGGTCGGCGCGTCGAGCGTCGGCGCCCAGGGCTCGGACCTGGCCGGCTCGCTCAACGGCACCAGCGAGCGGGTGGGGGCCGGCGCGTCCGGCCCGGAGAGCAACGGCCACTGGGCGGGAAACATCCCCGGGGACACCCTGGACGCGGCGGCGCTGTCGACGGCCGGAGCCGTCAACGGTGCCGGCCCCAGCACCGACGAGACGCTGATCGACGACCTCCCGGTCTTCGCCACGGCGCGGTCGAGCTGGTTCGTGGCGGAGAAGCCCCGTGGCAGGAACCGGACAGACGACGAGGGGGACGACGACGGGCCGATCCCGCCGCGCCGCCCCGGCGAGCTGACCGGTCCGACGCGGCGGGCCGAGCTCCCGCCGTCCCAGGACGGAGCCGGCTACCCGGAGGACTCGGGGGACGCGGGCTGGTCCGACGGACGGTCCGACCCGTCGGCCTCACTGTTCGGCCCGCCTCCGGGCGGCGGCGAGTTCGGCGGCTCGCTGTTCAGCGCTCCGCCTGACACCGGTCAGTTCAGCGGCTTCGGTCCGAACGGCTTCGGTGACGGCGGCGGCTACGGTGACGCGGGCTTCGGTGACAGCGGCGGCTACGCCGGCGGCTTCGGTGGCGGCGCGACCGATGTCGGCGCCAACGGCATGGCCGGCAACGGATCGGGTGGCTTCGCTGACTCGGATTACCACACCGCCGAGTTCAGCCGGTCCGGTTTCGGCACCGGCGGCGGCTTCGGGAACGACAGCGGTCACGGGAACGACGGCGGTCACGGGAACGACGGCGGTCCCGGGAACGACGGCGGCCTGGGGCAGGAGACCGGCGACGGCTTCGGCTCGGCCGGTGGTTTCGGTTCGGGTGACGGCTTCGGTTCGGCTGACTCCCAGCCCGGGGCCGGGCTGCCGTCCCGCTCCCGGACCGGGCGGGCCTCGGGCGACTACGCCCGCGCCGACTACACGCCACCGGGCCAGCAGGGCCCGGCCGGGGACGGGACCGGCTACCGCGAGCCCCGCGCGGACCGCGGCCAGGAATTCGGCCGTCCCATGCGGGAGAACGGGTACGGCGGGGCGGAACAGGCCTACCCCGGACGCCAGGACGGCGGCATCGGCGACGGCGCCTTCCGCCGCTCGGCCCGGTCGTCGCACCCGGGGCAGTCCACCGGTGGGGGCTCCGCCTACCCCGGGGCCAACCCGCCGCCGGCGGCGCCGCCGTTCGACACGGCAGCCGCCGCGGCGGAGGAGTCCGCCGACGACGGTCTCGACGAGCTCGGCCTGCCCAAGCGGCGGCGGCGCGCGAACCTGGCGCCGCAGCTGCGCCGGGAGAACGCGGACGCGGGCCGTTCGTCGCTCGCCGCGGGCCCTCGTTCACCCGAGGAGATCCGCAGCATGATGTCGTCCTTCCAGGCCAACTTCGGCCGTGGGATTGAGGACGGAACGGTGTCCAATGACGGAGATGATGTGAGGAAGGTAACCTGA	MLRNWPIRSKLVVILIVPLAALAVLSAIQVRGDVDNVRAAGRIEALADFSIKGNNLVHVLQRERYATNSYVGSNFLIPMLGQQAVDARKPVDDALAIYLADEQALPASARDALGSTLSSIRTHLDQLGEHRKQIDAHQTEIASNGAFYNEAVNELLLLNARIAAGSSDAKLVNGSTTLAGIAQAKEQASQQRGSVAQMLSMGNPTPQMLRALLAYAGAETAWTEQFRSTATPAELELFTNTVGRSATGVNQMRDDVVNRFSGQQAPDVGLEAWRTAADSKIAQMHDVEVQIANDLAATSRDIASTASRDALLGSIGVAIILVLSVVISLLVASPMIGQLRRLRGGALDVANDRLPSVVERLHRGEPVDIDAESFPVPATSKDEIGQLAEAFATVHEVAVRTAVEQAAMRKSIGDTFLNLARRSQALIHRQLKIIDALERKETDPDELEELFRLDHLATRMRRHAEDLIVLSGSKPARGWRRPVPIKDVVRGAVAEVEDYTRVKVLPITGGAVSGHAVGDVIHMFAELIENATSFSPPHTPVQVAGHPVSNGFVVEIEDRGLGMNQEEIDALNNRLANPPPFDLSTSERLGLFVVSRLAERHDVQVRLRPSPYGGTMAIVLLPATLLRASDDKGEDSGPREFAAVGASSVGAQGSDLAGSLNGTSERVGAGASGPESNGHWAGNIPGDTLDAAALSTAGAVNGAGPSTDETLIDDLPVFATARSSWFVAEKPRGRNRTDDEGDDDGPIPPRRPGELTGPTRRAELPPSQDGAGYPEDSGDAGWSDGRSDPSASLFGPPPGGGEFGGSLFSAPPDTGQFSGFGPNGFGDGGGYGDAGFGDSGGYAGGFGGGATDVGANGMAGNGSGGFADSDYHTAEFSRSGFGTGGGFGNDSGHGNDGGHGNDGGPGNDGGLGQETGDGFGSAGGFGSGDGFGSADSQPGAGLPSRSRTGRASGDYARADYTPPGQQGPAGDGTGYREPRADRGQEFGRPMRENGYGGAEQAYPGRQDGGIGDGAFRRSARSSHPGQSTGGGSAYPGANPPPAAPPFDTAAAAAEESADDGLDELGLPKRRRRANLAPQLRRENADAGRSSLAAGPRSPEEIRSMMSSFQANFGRGIEDGTVSNDGDDVRKVT	MIGSLTARIFAIFWLTLALVLMLVLMLPKLDSRQMTELLDSEQRQGLMIEQHVEAELANDPPNDLMWWRRLFRAIDKWAPPGQRLLLVTTEGRVIGAERSEMQIIRNFIGQADNADHPQKKKYGRVELVGPFSVRDGEDNYQLYLIRPASSSQSDFINLLFDRPLLLLIVTMLVSTPLLLWLAWSLAKPARKLKNAADEVAQGNLRQHPELEAGPQEFLAAGASFNQMVTALERMMTSQQRLLSDISHELRTPLTRLQLGTALLRRRSGESKELERIETEAQRLDSMINDLLVMSRNQQKNALVSETIKANQLWSEVLDNAAFEAEQMGKSLTVNFPPGPWPLYGNPNALESALENIVRNALRYSHTKIEVGFAVDKDGITITVDDDGPGVSPEDREQIFRPFYRTDEARDRESGGTGLGLAIVETAIQQHRGWVKAEDSPLGGLRLVIWLPLYKRS	247.70	gnl|BL_ORD_ID|136|hsp_num:0	152		
BGC0001197.1|Frankiamicin_3 # 3936 # 4307 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.683	BGC0001197.1|Frankiamicin_3 	3936	4307	+	Loose	500	24.6386	LCR-1	38.0	3002997	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	LCR beta-lactamase	GTGTCAGGGGATGAGGAATGGTTCGACGACGAGGCCGGGCCGGTGGTGAGGCCCTACGCCGTCACGGGGGGGCGCACCCGTCCCAGTAACCGGACCCTGGATCTGGTGGCCCTGGTGTCCACCTCTCCGCAGGGGCGGGCCATCGCGACCACGCTGGAACCGGAGCAGCGTGCCATAGCGGTGCTCTGCCAGCGGCTCCAGTCCGTCGTCGAGATCTCCGCCCGACTCAACCTCCCAGTCGGCGTGGCACGTGTGCTCGTCGGCGACATGCTCGACGCCGGGCTGGTGAGTGTGCACCGGCCCGAACGAACGTCGGACCGCCCCAGCGTGGCGATTATCGAAAAGGTGCTCAGTGGACTCCAGGCTCTCTAG	MSGDEEWFDDEAGPVVRPYAVTGGRTRPSNRTLDLVALVSTSPQGRAIATTLEPEQRAIAVLCQRLQSVVEISARLNLPVGVARVLVGDMLDAGLVSVHRPERTSDRPSVAIIEKVLSGLQAL	MLKSTLLAFGLFIALSARAENQAIAKLFLRAGVDGTIVIESLTTGQRLVHNDPRAQQRYPAASTFKVLNTLIALEEGAISGENQIFHWNGTQYSIANWNQDQTLDSAFKVSCVWCYQQIALRVGALKYPAYIQQTNYGHLLEPFNGTEFWLDGSLTISAEEQVAFLRQVVERKLPFKASSYDSLKKVMFADENAQYRLYAKTGWATRMTPSVGWYVGYVEAKDDVWLFALNLATRDANDLPLRTQIAKDALKAIGAFPTK	47.31	gnl|BL_ORD_ID|847|hsp_num:0	901		
BGC0001197.1|Frankiamicin_4 # 4288 # 4911 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.671	BGC0001197.1|Frankiamicin_4 	4288	4911	+	Loose	800	25.0238	msrA	43.48	3000251	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	GTGGACTCCAGGCTCTCTAGGACCCGAGCGGCCGATACACCGGCGCCGCATCCGGTAAAGATCATCGTTGCCGGTGGTTTCGGAGTCGGGAAGACGACGTTCGTCGGCGCCGTGAGCGAGATTCCCCCGCTCACCACCGAGGCCGCGATGACGTCCGCGAGTATCGGTGTTGACGACACCAGCGCCGTCGCCTCCAAGACGACGACGACGGTGGCCATGGACTTCGGTCGAATCACCCTGGTCGACAGCGTGATTCTCTACCTGTTCGGGACCCCCGGCCAGGACCGCTTCTGGTTCATGTGGGACGAACTCGTCCTGGGTGCGATCGGCGCGATCGTGCTCGTCGACACCCGACGTCTCGCCGACTCGTTTCCCGCCATCGACTACTTCGAGGAACGTGACATCCCGTTCCTCATCGCCCTGAACCACTTCGAGGGCGCGCGCCGTTACCGCAGCGAGGACATCCGCGCGGCGCTGGACCTCGACCCCCGCCGGCCGATGGTGCTGTGCGACGCCCGCCAGCGGGAGTCGGTGCGCCAGTCGCTCATCGCGTTGGTCCGCCACGCCCTGGAGGTGGTCTCCGCGGAGAGCCAGCGACCGGGACTGCCGACCGGCTCACGGTGA	MDSRLSRTRAADTPAPHPVKIIVAGGFGVGKTTFVGAVSEIPPLTTEAAMTSASIGVDDTSAVASKTTTTVAMDFGRITLVDSVILYLFGTPGQDRFWFMWDELVLGAIGAIVLVDTRRLADSFPAIDYFEERDIPFLIALNHFEGARRYRSEDIRAALDLDPRRPMVLCDARQRESVRQSLIALVRHALEVVSAESQRPGLPTGSR	MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLRNVISNYSPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKEKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT	42.42	gnl|BL_ORD_ID|1132|hsp_num:0	1200		
BGC0001197.1|Frankiamicin_5 # 4908 # 5972 # 1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.717	BGC0001197.1|Frankiamicin_5 	4908	5972	+	Loose	1900	26.1794	AcrF	23.17	3000502	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAACGACACCGCGCGTGCCGCCCCAGCGCCCGCGGACCATCCGCTTCGACCTGGGAAGGGGATCTTGCTGGAGCTTCTTGGTCTCGACGACGTCACGCTGTCGGCCTACCGGTTGTGGCTGAGACATCCCGACATGGATGTCGACGGGGTGGCCACGGCGGTGGGGCAGGCGAACGACACAGTCCGCCGGTCACGGGACCGGCTCGTCGAGCTGTCACTGCTGTTGCCCTCCACCGAACACCCCGGCCACCTGGTCGCCGTCCACCCGGAGGCCGGTCTGGAGCATCTGCTCCAGGCTCAGCACGAGGCACTCATCCGCCGCCACGAGCGGCTTGTCCGGGCACGGGCGCAGGTGAGCACGTTCGTCTCGGAGTACCTGGACAACCGGCCCGGTGGGGACGGCGCGGAGGTCGAGCACATCGACAGCGCCGACCAGGCCCGGGCCGAACTGCTCACCCTTGTCGGCCGGGCCGAGAAGGAGGTGCTCGCGCTGCACACCCGGCGCGGCCGCCCGCCGGCGTTGACCGCGGAGGTTCTCCCGGTCGAGCTGCGGGCGCTGCAGCGCGGTGTGGCGATGCGCAGCGTCCTCCCACGCACGGTCAGCACCGACGAGACGGGTGTCGGCTACGTCCGCACGGTCGCCTCGCACGGCCTGGAGGCCCGGCTCGCCGACGACCCGCGCATCGACGCGACGACCGTGGACGGCCGGGTCGGGCTGGTGCAGTTCGTGCAGCACGGCACCGACCCGCACGCGCTGATCGTGCGCTCGCCCGCGCTGGCGAACCTGGTCACCATGCTGTTCGAGCAGGTCTGGGACAGCGCCGAGCCGCTGGCCGCGGAGGCCGACGGCGACCTGGAGAGCCCTGCGGACGACCGGCCGAACGACACCGAGCGGCTGCTTTTAAGGCTGCTCAGCCTGGGTGTGAAGGACGAGGCAGCGGCCCGCCATCTCGGGGTGTCCGTCCGTACGGTGCGTCGGATGGTCGCCGACCTCATGACCCGCCTGGACGCCCGTAGCCGCTTTCAGGCCGGGACGGTCGCGGCCCGGCGGGGTTGGTTGTAG	MNDTARAAPAPADHPLRPGKGILLELLGLDDVTLSAYRLWLRHPDMDVDGVATAVGQANDTVRRSRDRLVELSLLLPSTEHPGHLVAVHPEAGLEHLLQAQHEALIRRHERLVRARAQVSTFVSEYLDNRPGGDGAEVEHIDSADQARAELLTLVGRAEKEVLALHTRRGRPPALTAEVLPVELRALQRGVAMRSVLPRTVSTDETGVGYVRTVASHGLEARLADDPRIDATTVDGRVGLVQFVQHGTDPHALIVRSPALANLVTMLFEQVWDSAEPLAAEADGDLESPADDRPNDTERLLLRLLSLGVKDEAAARHLGVSVRTVRRMVADLMTRLDARSRFQAGTVAARRGWL	MANFFIRRPIFAWVLAIILMMAGALAILQLPVAQYPTIAPPAVSVSANYPGADAQTVQDTVTQVIEQNMNGIDNLMYMSSTSDSAGSVTITLTFQSGTDPDIAQVQVQNKLQLATPLLPQEVQQQGISVEKSSSSYLMVAGFVSDNPGTTQDDISDYVASNVKDTLSRLNGVGDVQLFGAQYAMRIWLDADLLNKYKLTPVDVINQLKVQNDQIAAGQLGGTPALPGQQLNASIIAQTRFKNPEEFGKVTLRVNSDGSVVRLKDVARVELGGENYNVIARINGKPAAGLGIKLATGANALDTAKAIKAKLAELQPFFPQGMKVLYPYDTTPFVQLSIHEVVKTLFEAIMLVFLVMYLFLQNMRATLIPTIAVPVVLLGTFAILAAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVMMEDKLPPKEATEKSMSQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATLLKPVSAEHHENKGGFFGWFNTTFDHSVNHYTNSVGKILGSTGRYLLIYALIVAGMVVLFLRLPSSFLPEEDQGVFLTMIQLPAGATQERTQKVLDQVTDYYLKNEKANVESVFTVNGFSFSGQAQNAGMAFVSLKPWEERNGDENSAEAVIHRAKMELGKIRDGFVIPFNMPAIVELGTATGFDFELIDQAGLGHDALTQARNQLLGMAAQHPASLVSVRPNGLEDTAQFKLEVDQEKAQALGVSLSDINQTISTALGGTYVNDFIDRGRVKKLYVQADAKFRMLPEDVDKLYVRSANGEMVPFSAFTTSHWVYGSPRLERYNGLPSMEIQGEAAPGTSSGDAMALMENLASKLPAGIGYDWTGMSYQERLSGNQAPALVAISFVVVFLCLAALYESWSIPVSVMLVVPLGIVGVLLAATLFNQKNDVYFMVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGVVEATLMAVRMRLRPILMTSLAFILGVLPLAISNGAGSGAQNAVGIGVMGGMVSATLLAIFFVPVFFVVIRRCFKG	34.24	gnl|BL_ORD_ID|1351|hsp_num:0	1437		
BGC0001197.1|Frankiamicin_6 # 6305 # 6682 # 1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.667	BGC0001197.1|Frankiamicin_6 	6305	6682	+	Loose	1500	25.0238	rphA	34.38	3000444	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	GTGCCGACGGAATCCGGCTCGGTTCCGAACCAACGCACGACCAGCCAGCGGACGCTGATTGTCGCCCGGATGAACCCCGAAGACGCTGGTGCGGTCGCCGACGTCTTCGCGGAGTCGGACGCCGGCGAGCTTCCACATCTCGTCGGCGTCGCCCGGCGCGACCTTTTCCGTTTCCACGGGCTGTACTTCCATCTCATCGAGAGCCGGGCGGACATCAACGGCACGCTGCCGCCGGTTCGGGAGCACCCGCTGTTCGTCGACGTGAACAGCAAGCTCGAGAAGTACATCGCGGCGTACGACCCGCAGACCTGGCGCGGCCCCCGGGACGCGATGGCCGACAGTTTCTACACCTGGGTGGCCGATCAGAACGGTCCCTGA	MPTESGSVPNQRTTSQRTLIVARMNPEDAGAVADVFAESDAGELPHLVGVARRDLFRFHGLYFHLIESRADINGTLPPVREHPLFVDVNSKLEKYIAAYDPQTWRGPRDAMADSFYTWVADQNGP	MSGRLVVDLQDVDAAGLAEVGGKGAHLGELSRIDGVRVPSGFCVTTHAFRRIMAEAPESGELLDRLSRVDEGDQEAVRSLAARLRQVVGATPLPDEVAAAVTGALARHGERSAYAVRSSATAEDLPTASFAGQQDTYLNVVGTEEILRHVSRCWASLFTERAVTYRGRQGVDHRTVHMGVVVQRMVVPRASGILFTADPVTGDRRTATVDAGFGLGEALVSGLVDPDVLTVRHGEVVARTIAAKRRALHAVQGGGTRETPIEERRQREPVLTDDQAVELVALGRRIEAHFGSPQDIEWCLDDDGFHIVQSRPITTLFPVPERDDDVFRVYLSVGHQQMMTDAMKPLGLSMWRLTALAPMYEAGGRLFVDATARLAVPGSRATLLDVVGRGDPLTRDALETVLENGEFEPTPAETDGGAPPAGDGAEPDEADPSIVTELIERSRRSLAELEREIGTKSGPALFAFLREAFEEHKRVVGDPLNIRAIMAGMEATWWLNDRLEEWLGEKNAADTLTLSAPDNVTSEMGLELLDVADVVRTHPEVVAFLEGVEDDGFLDELPKVPGGAEARDAFEAYLDRYGMRCVGEIDITXPPVRERPSALVPVVLDHVRAFGPGAAARRFEDGRRRALAKEREVLERLRDLPDGERRADAARRMIRQVRAFAGYREYPKYAIVSRSFVYRQALLREADELVRAGVLADREDVHYLTFDEFEEAVRVRRVDERLVRRRKDAFRSYQALTPPRVLTSEGVALSGAYRRDDVPEGALAGLAVSAGTVEGRARVVLDMAEADLEAGDILVTRFTDPSWSPLFVGIAGLVTEVGGLMTHGAVIAREYGLAAVVGVERATRLIRDGQRIRVHGTEGYIELLS	14.45	gnl|BL_ORD_ID|911|hsp_num:0	910		
BGC0001197.1|Frankiamicin_7 # 7083 # 7340 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.686	BGC0001197.1|Frankiamicin_7 	7083	7340	+	Loose	740	24.6386	tet(30)	27.27	3000561	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCCCCTGCAGTGGACCGCCGACGAGCTTCTCGACTTCCTCGTGGAGCAGGCCGGCCTGCCGCCGGAGGACCGTCCGGCCGAACTCGGCGTGACGTTCACCGACATCGGTCTGGACTCGCTCGCCTACCTGCAGCTCCAGGCCGAGGTACAGGAGCGGTTCGGCGTCGACCTGCCGAACGAGGCGCCGGAGGGATACACCCTCGCCGACATCCTCACCACGGTGAACAGCGCGCTCCTGCAGTCCGAGGTCGCCTGA	MPLQWTADELLDFLVEQAGLPPEDRPAELGVTFTDIGLDSLAYLQLQAEVQERFGVDLPNEAPEGYTLADILTTVNSALLQSEVA	MNKALIVILSTVALDAIGAGLIFPILPDILVEVTGGGDIGFLYGVMLGVFAVMQFVFSPILGALSDRFGRRPVLLLSLAGTLLDYLVMAFSPLGWVLVVGRAMAGITSANMAVASAYITDITPAEQRAQRFGTVGAVMSLGFIIGPVIGGVIGAWWLRAPFLVAALFNGLNLFVALFVLPESRKAGPGKFAFKELNPLAPLVWLWNFKPLLPLVTVSVVFGLVAAIPGTIWVLYGAERFGWDSVHMGLSLSVFGVSGALAQAFLVGPLSRRFGDLGTLMIGVGFDMLAYMLMAFANQSWMGYAVAPLFALGGVAMPALQSLVTSRVSDDQQGQLQGVLASLMSLAGIIGPVLTTAVFFSTKSIWIGTIWLVGAALYLLALPLFATVKTPKAVAA	21.57	gnl|BL_ORD_ID|1833|hsp_num:0	1917		
BGC0001197.1|Frankiamicin_8 # 7391 # 7885 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.665	BGC0001197.1|Frankiamicin_8 	7391	7885	+	Loose	500	23.0978	RCP-1	33.33	3003563	protein homolog model	n/a	n/a	penam	antibiotic inactivation	RCP beta-lactamase	ATGAGCGGGCACACCGACAACTCGATCTTCATCGATGCCGACATCGACCTCGTCTGGTCCATGACGAACGACCTGGAGTCCTGGCCGTCGCTGTTCACCGAGTACGCCTCGGTCGAGATCCTCGAGAAGGCCGAGAACACCTTCAAGTTCCGGCTGACGATGCACCCGGACGAGAACGGGACGTCCTGGAGCTGGGTGTCCGAGCGCACCCTCGACCCGGTGAACCACAAGGTCCGCGCCTACCGGGTGGAGACGGGGCCCTTCGAGTACATGCACATCGAGTGGACCTACCTGCCCGAGGGCACCGGCACCCGGATGCGCTGGGTGCAGGACTTCCAGATGCGCCCGACGGCACCGGTCACCACCGAGCAGATGACCCAGCGGATCAACACGAACACGCCGCGCGAGATGGCGTCCATCCGCGGCAAGGTCGAGGCGGCGGCCAGCGCCGCCGCGCCGGCAGCCGACCAGGTCCAGGTTCCCGAGCAGGTCTGA	MSGHTDNSIFIDADIDLVWSMTNDLESWPSLFTEYASVEILEKAENTFKFRLTMHPDENGTSWSWVSERTLDPVNHKVRAYRVETGPFEYMHIEWTYLPEGTGTRMRWVQDFQMRPTAPVTTEQMTQRINTNTPREMASIRGKVEAAASAAAPAADQVQVPEQV	MRFTATVLSRVATGLALGLSMATASLAETPVEALSETVARIEEQLGARVGLSLMETGTGWSWSHREDELFLMNSTVKVPVCGAILARWDAGRLSLSDALPVRKADLVPYAPVTETRVGGNMTLDELCLAAIDMSDNVAANILIGHLGGPEAVTQFFRSVGDPTSRLDRIEPKLNDFASGDERDTTSPAAMSETLRALLLGDVLSPEARGKLAEWMRHGGVTGALLRAEAEDAWLILDKSGSGSHTRNLVAVIQPEGGAPWIATMFISDTDAEFEVRNEALKDLGRAVVAVVRE	55.97	gnl|BL_ORD_ID|917|hsp_num:0	882		
BGC0001197.1|Frankiamicin_9 # 7896 # 8318 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.716	BGC0001197.1|Frankiamicin_9 	7896	8318	+	Loose	300	25.0238	AAC(3)-Ic	28.85	3002531	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	GTGAGCATCGCAACCCCCGCACCCCTGACGGTCCCCAAGGTCCTCTCGATCCACGACGTGCCGGCCAACCGGCGCCGCGGCGGTGACATCCGCACGCTGCTGTCCCCGGCGACCGTCGGCGCCAAGTCCGGCTTCCTGGGAACTCTCACCCTGCAGCCCGGCGAGGTGGTGACCGAGCACTGGCACCCCTACTCCGAGGAGTTCCTCTACTGCGTCACCGGCGCGGTCACGGCCCGCCTCGACGGCGAGCACACCGCCCTGCCGGCCGAGCACGGCCTGCTCATCCCGATCGGCATGCGGCACCGGATCGTGAACACCGGCGACGACGTGGCCTTCCTCGTCTTCCACCTCAGCCCGCTCGCGCCGCGGCCCGACCTGGGGCACGTGGACACCGAGCCGCTGCCTGAGCAGTCGCAGCAGTGA	MSIATPAPLTVPKVLSIHDVPANRRRGGDIRTLLSPATVGAKSGFLGTLTLQPGEVVTEHWHPYSEEFLYCVTGAVTARLDGEHTALPAEHGLLIPIGMRHRIVNTGDDVAFLVFHLSPLAPRPDLGHVDTEPLPEQSQQ	MISTQTKITRLNSQDVGVMRAMLGMFGEAFEDAENYCRAQPSDSYLQDLLCGSGFIAIAALQGQEVIGGLAAYVLPKFEQQRKEIYIYDLGVQGAYRRRGIATALINELQRIAHDIGAYVIFVQADYGDDPAVALYTKLGIREDVMHFDIEPQPAA	89.74	gnl|BL_ORD_ID|1063|hsp_num:0	1131		
BGC0001197.1|Frankiamicin_10 # 8315 # 9667 # 1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.731	BGC0001197.1|Frankiamicin_10 	8315	9667	+	Loose	750	197.593	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	35.61	3003463	protein variant model	F413L	n/a	isoniazid	antibiotic target alteration	antibiotic resistant kasA	GTGAGCAAACCCACGCAGCGGTCGCGGCCGGACGACGCTCACGGGCCGGCGTCACGGGACGGGGGTCCGCGCCGCACCGCGGTGACCGGGGTCGGCGTCGTCGCCCCCGGTGGCTCGAACCGCAAAGAGTTCTGGACCCTGCTCACAGACGGCCGCACCGCCACCCGCCGGCTGTCCTTCTTCGACCCGTCGCCGTTCCGGTCGCAGGTCGCGGCCGAGTGCGACTTCGACCCGCTCGCCGCCGGCCTCACCCGCCAGGAGATCGCGCGCAACGACCGGTTCGTGCAGTTCGCGCTGGCCGCGGCCGCGGAGGCGGTGGCCGACAGCGGGTTGGACCTCGGCCTCGGTGTCGGCGGCACCGAACGCGAGCCGGGCGACGGGCCGGTCGTCGGGGTGAGCATGGGCAGCGCCGTCGGGGCGACCACCCGGCTCGAGAACGAGTACGTGGTCGTCAGCGACGGCGGGAAGCACTGGGAGGTCGACCCGCGCTACGCGAGCTCGTTCCTCTACCACGCGCTCGTGCCGAGCTGCCTGGCCACCGAGATCGCCTGCCGCTTCGGCGCGCACGGCCCGTCGTTCGTGGTCTCCACCGGGTGCACCTCCGGCATCGACGCGGTCGGCTACGGCCACCAGCTCATCGTCGACGGCGAGGCGGACATCGTGATCGCCGGCGCCTCCGACGCGCCGCTCTCGCCGATCTCCATCGCCTGCTTCGACGCCATCCGCGCCACCTCGGCCCGCAACGACGACCCCGAGCACGCCTCGCGGCCGTTCGACGCCAGCCGCGACGGCTTCGTGATGGGGGAGGGCAGCGCCGTGCTGATCCTCGAGGAGCTGGAGTCGGCCCGGGCCCGCGGCGCGCACATCTACTGCGAGGTCGGCGGGTACGCCTCGCGGTCCAACGCTTTCCACATGACCGGCCTGCGCCCGGACGGCGTCGAGATGGCCGAGGCCATCCGCATCGCCCTGGACCAGGCGCGGCTCGACCCGTCCGCCGTCGACTACGTCAACGCCCACGGGTCGGGGACGAAGCAGAACGACCGGCACGAGACGGCCGCTTTCAAACGGTCGCTGGGCGCCCACGCCCACGAGGTGCCGGTCAGCTCGATCAAGTCGATGGTCGGCCACTCCCTCGGCGCGATCGGCTCCATCGAGCTCGCGGCCTGCGCGCTGGCGATCGAGCACAACGTGGTGCCGCCGACGGCGAACTGGTCGACCCGCGACCCCGAGTGCGACCTGGACTACGTCCCGAACACCGCCCGCGACCACACGGTGGACGCGGCGCTGTCGGTCGGCAGCGGGTTCGGCGGGTTCCAGTCGGCCATCGTCCTGACCTCGGCGGACCGGGCATGA	MSKPTQRSRPDDAHGPASRDGGPRRTAVTGVGVVAPGGSNRKEFWTLLTDGRTATRRLSFFDPSPFRSQVAAECDFDPLAAGLTRQEIARNDRFVQFALAAAAEAVADSGLDLGLGVGGTEREPGDGPVVGVSMGSAVGATTRLENEYVVVSDGGKHWEVDPRYASSFLYHALVPSCLATEIACRFGAHGPSFVVSTGCTSGIDAVGYGHQLIVDGEADIVIAGASDAPLSPISIACFDAIRATSARNDDPEHASRPFDASRDGFVMGEGSAVLILEELESARARGAHIYCEVGGYASRSNAFHMTGLRPDGVEMAEAIRIALDQARLDPSAVDYVNAHGSGTKQNDRHETAAFKRSLGAHAHEVPVSSIKSMVGHSLGAIGSIELAACALAIEHNVVPPTANWSTRDPECDLDYVPNTARDHTVDAALSVGSGFGGFQSAIVLTSADRA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	108.17	gnl|BL_ORD_ID|2018|hsp_num:0	1943		
BGC0001197.1|Frankiamicin_11 # 9664 # 10950 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.769	BGC0001197.1|Frankiamicin_11 	9664	10950	+	Loose	750	117.857	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	32.08	3003463	protein variant model	F413L	n/a	isoniazid	antibiotic target alteration	antibiotic resistant kasA	ATGACCGTCCTCGACACCGCGCCGTCCGGGACGGCCGGCCCGGCCCGGCCGGCCGCGGGCGCGGTGCGGCCGGTCATCACCGGGCTCGGGGTCATCGCGCCCAGCGGGGTGGGCCTCGACGCGTACTGGGCCTCGACGCTGCGCGGCGAGCTGCGCGTCGCGCCGATCACCCGCTTCGACGCGAGCCGCTACGACACCCGGATCGCCGGCGAGGTCCCCGACTTCGCCGCCGAGGAGTTCGTCGACCACCGCTACCTCGTGCAGACCGACCGCTGGACCTGGATGGGCATGGCCGCGTCCAAGCTGGCGCTGGCCGACGCAGCCTACGACCCGGCCGAGCACGACCCGTACGAGACGTCGGTGGTCTTCGGCAGCGGCTCGGGGGGCAACGACTTCGGCCAGCGGGAGCTGTCCCGGCTGTGGACGCGGGGGCGCACCGCGGTCAGCGTCTACCAGTCGATCGCCTGGTTCTACGCGGCGACGACCGGCCAGACCTCGATCCGGCACGGGCTCAAGGGCCCGTCGGGCGTCCTCGTCTCCGACGGCGCCGGCGGCGTCGACAGCCTCGCCCAGGCCCGGCGGACCATCCGGCGCGGCACCCCCACGGTGCTCGCCGGCGGCGCCGAGTGCGGGCTGACGCCGTACGCGCTGACCTGCCACCTCAGCAGCGGCCGGGTCAGCTCCGCGGCGAGCCCCGCGGACGGCTACAAGCCGTTCGACGTCCGCGCCAACGGTTACCTGCCCGGTGAGGGCGGGGCGACCCTGCTCGTCGAGGACCCGGCTGCCGCGGCCCGCCGCGGCGCCCGCGTCTACGGCGAGATCGCCGGCTACGCGGCCACCCACGACGGCGCGCACCACGAGCAGGCGCCGGCGGACTCGCGCTGGCTGGCCGCGGCGATGCGCCGCGCGCTCGCCGACGCGGAGCTCACCCCCGCCGACGTCGACGTCGTGTTCGCCGACGGCGCCGGCTCCCCGGACCTCGACGCGCTGGAGGCGGAGGCCATCCGGGCCGTCTTCGGCGCCGGAGCGGTGCCCGTCACCGCCCCGCAGGGGCTCATCGGACGGCTGTGCGCCGGCGGCTCCGCCCTCGCCGCGGCGACCGCGCTGCTGTCGATCCGCGACGGGGTGATCCCCGCCGTGGGCAACCTCGACGAGCCCGACCCCGCCCACGGCCTCGACCTGGTGCGCTCGCCGCGTGAGGGCCGTGTCCGGGCCGCGCTGGTCAACGCGCGCGGCCACGGCGGGTTCAACAGCTCGCTCGTCCTGCGGGCGGTCGACACCGACTGA	MTVLDTAPSGTAGPARPAAGAVRPVITGLGVIAPSGVGLDAYWASTLRGELRVAPITRFDASRYDTRIAGEVPDFAAEEFVDHRYLVQTDRWTWMGMAASKLALADAAYDPAEHDPYETSVVFGSGSGGNDFGQRELSRLWTRGRTAVSVYQSIAWFYAATTGQTSIRHGLKGPSGVLVSDGAGGVDSLAQARRTIRRGTPTVLAGGAECGLTPYALTCHLSSGRVSSAASPADGYKPFDVRANGYLPGEGGATLLVEDPAAAARRGARVYGEIAGYAATHDGAHHEQAPADSRWLAAAMRRALADAELTPADVDVVFADGAGSPDLDALEAEAIRAVFGAGAVPVTAPQGLIGRLCAGGSALAAATALLSIRDGVIPAVGNLDEPDPAHGLDLVRSPREGRVRAALVNARGHGGFNSSLVLRAVDTD	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	102.88	gnl|BL_ORD_ID|2018|hsp_num:0	1943		
BGC0001197.1|Frankiamicin_12 # 11053 # 11790 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.724	BGC0001197.1|Frankiamicin_12 	11053	11790	+	Loose	450	54.6842	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	26.46	3004045	protein variant model	F203A	n/a	isoniazid; triclosan	antibiotic target alteration	antibiotic resistant fabI	ATGTTCCCAGACCTGGCCGGCAAGCGTGCCCTGGTCACCGGCGGCACGCGCGGTATCGGCCGGGCCGTCGTGCTCGGGCTCGCCCAGGCCGGCGCCACCGTCGTGGTCGGCCACCAGCGCCAGACCGAGGACGCCGAGAGCCTGCGCCGCGAGCTCAAGGACACCGGCAACGATCACCTGCTGGTGCAGGCCGACGTCGCCGACCCGGCGCAGATCACCGAGCTGGTGTCGGCGACCGGCACCCACCTCGGCGGCCTCGACATCGTCGTGAACAGCGTCGGGACGATCAGCCACATCCCGTACGCCGACCTGCCGCTGGACGCCTGGACGCAGGTGCTGACCACCAACCTGACCGCGACCCACCTCGTCACCCAGGGTGCGCTGCCGCTGCTCGGCGACTCCGGGACGGTCGTCAACATCGGGTCCGGCGCCGGGCTCGTCGGCGTGCCGCTGCGCGCCCACTACACGGCGGCCAAGACGGGCCTGATCGGCCTCACCCGCTCGCTGTCCAAGGAGCTCGGCTCCAAGGGCATCCGGGTGAACCTGGTCTCGCCGGGCGTCATCGAGACCGACCAGGCGGCCGGCATGCCCCCGGCGGCGCGCGCCGCGTACACCAACCGCATCCCGCTGGGCCGGCTCGGCGAGGCCAACGAGGTCGCCGCCGTCGTCCTGTTCCTCGCCAGCGACGTGTCCAGCTACGTCAACGGCGCCACCTTCACGGTCGACGGAGGAATCTGA	MFPDLAGKRALVTGGTRGIGRAVVLGLAQAGATVVVGHQRQTEDAESLRRELKDTGNDHLLVQADVADPAQITELVSATGTHLGGLDIVVNSVGTISHIPYADLPLDAWTQVLTTNLTATHLVTQGALPLLGDSGTVVNIGSGAGLVGVPLRAHYTAAKTGLIGLTRSLSKELGSKGIRVNLVSPGVIETDQAAGMPPAARAAYTNRIPLGRLGEANEVAAVVLFLASDVSSYVNGATFTVDGGI	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	93.51	gnl|BL_ORD_ID|2390|hsp_num:0	2666		
BGC0001197.1|Frankiamicin_13 # 11790 # 12113 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.688	BGC0001197.1|Frankiamicin_13 	11790	12113	+	Loose	950	23.483	tcr3	31.25	3002893	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGGCCACCCCCAGCCGTTCCGCATCATGCTGACCATGCACATCCACCCGGGCCGCGAGCAGGAGTTCGAGCAGACCTGGCTGCGGATCGGGGACGGCGTGACCAGCCACCCGGCGAACCTCGGCCAGTGGCTGATCCGCTCCGAGGACGAGCCGAGCACGTACTACATCATCAGCGACTGGGTGGACGAGCCGAAGTTCCGCGAGTTCGAGCTGAGCCCCGGGCACCTGGAGCACCGCAAGATCCTCCACCCCCTGCGGGCCAGCGGCTCGATGGTCACCGGGACCGTGCTCACCCACCTTGTCGGCGCGGCGGCCGAGTGA	MGHPQPFRIMLTMHIHPGREQEFEQTWLRIGDGVTSHPANLGQWLIRSEDEPSTYYIISDWVDEPKFREFELSPGHLEHRKILHPLRASGSMVTGTVLTHLVGAAAE	MGMANATSQTGEAVADEAGGPAGFTHRQIITALSGLLLAVLLAALDQTIVSTALRTIGDQLHGQTVQAWVITGYLVSSTIAMPFYGKLSDIYGRKPLYLAAIAVFIVGSAACAMANSMETLAIARVLQGFGGAGLMSLPTAVIADLAPVRERGRYFSYLMMAWVAASVLGPLVGGLFAGAGEILGVTGWRWAFLINVPLGLVALLSVRKALNLPHRRVDHPIDFRGALTLALCLVPLLIVAEEGLDWGWGSARSLTLFAVSLIGLVLFVLAERARGLEAMVPLRLFRRGGITMATAVNFTIGVGIFGTVSTLPLFLQLVQGRSATVAGLVIIPVMTGAIVSQTICAKIIKKWNRYKKPAIVGLGSMAGALLSLSAAGADTPLAVIVVIAAWLGFGIGLSQTVITLAIQSSAPKSELGVANAASGLFRQLGGTSGAAVFMSVLFGVAAGRLDGADPDEAVRRALSDPGSTGGLSASAVDAFTSGFDTMFLVGGLILAVGFLLTFPLRELRDEE	20.90	gnl|BL_ORD_ID|607|hsp_num:0	652		
BGC0001197.1|Frankiamicin_14 # 12110 # 12679 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=3-4bp;gc_cont=0.737	BGC0001197.1|Frankiamicin_14 	12110	12679	+	Loose	700	25.409	vanSM	32.65	3002939	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	GTGATCCGCCGCAAGAAGAAGGCGGATGCCCCGCCGGAGACCGACCCGCAGGAGACCGCCTCAGCGGAGTCGGCTCCAGCGGAGTCGGCCGCTGCGGAGTCGGCGACCGCGGAGCCGGCTGTGGCCGAGTCGTCCACTGGCGAGTCGGCTGTTGCCGGGTCGCCCGCGTCCGGCCCGGTCGAGGTCGAGGCCGAGGCCGAGGTCGAGGCCGAGGTCGAGGCTGAGGCCGGTGACGGTGGCCGGGTGCGGGTGATGCTGTGGGCGGTCGACCCGGCCGAGGATCAGGGCGCGGTCGAGCGGGCCTACCACGAGATCAGCTCCAAGCTGGTGGGCACGCCCGGCCTGCTCGGGAACCGCCTGCTGCGCTCCGCCGCCGAGCCGACGAAGTTCGCCGTCGTCAGCGAGTGGGCGAGCATGGCCGAGTTCGTGACCTGGGAACGCGGGGCGGACCACAAGCCGGCCACCTCGCCGCTGCGTCCGCTGCAGGACCCGGCGATGCGCGCGACCATCTTCACCGAGGTCGCCGCCTACGGCCCGGACGGCCCCTTCACCGAGCCGGACGGATTCTGA	MIRRKKKADAPPETDPQETASAESAPAESAAAESATAEPAVAESSTGESAVAGSPASGPVEVEAEAEVEAEVEAEAGDGGRVRVMLWAVDPAEDQGAVERAYHEISSKLVGTPGLLGNRLLRSAAEPTKFAVVSEWASMAEFVTWERGADHKPATSPLRPLQDPAMRATIFTEVAAYGPDGPFTEPDGF	MAKMRSSFRTKIILLFAVSMLLAGMVTYLLFKGLQLYYHTMIHRGNPLAELRDFIESIGDFNFFFLLFILLSLSVFYILTKPYSAYFDEISTGIQYLALGDFKRRVNIQSNDEFGDIAQAINQASEKLEEAIQRGDFSENSKEQLVVNLAHDLRTPLTSVLGYLDLVLKDEKLTKEQVRHFLTIAFTKSQRLEKLIDELFEITRMNYGMLSIEKKPINLTDLLLQLKEELYPIFEKNGLTARMNTLPHLPVSADGEMLARVFENLLTNANRYGHDGQFVDINGFVDEEEVVVQVVNYGDSIPPNELPYLFDMFYTGDKARTHKEDSTGLGLFIAKNIVEQHNGTVTAESSLIRTVFEVRLPLESAPIDQV	51.08	gnl|BL_ORD_ID|1251|hsp_num:0	1328		
